Aedes Mosquito Saliva Modulates Rift Valley Fever Virus Pathogenicity

PLoS Neglected Tropical Diseases

Volumn 7, Issue 6, 2013, Pages

  Le Coupanec, Alain ^a   Babin, Divya ^a   Fiette, Laurence ^a   Jouvion, Grégory ^a   Ave, Patrick ^a   Misse, Dorothee ^b   Bouloy, Michèle ^a   Choumet, Valerie ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

AEDES; AEDES AEGYPTI; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; COMPARATIVE STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HISTOLOGY; IMMUNOASSAY; LIVER INJURY; MALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; SALIVA; SALIVARY GLAND; SALIVATION; VIRUS CULTURE; VIRUS TITRATION; VIRUS VIRULENCE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; ISOLATION AND PURIFICATION; PATHOGENICITY; RIFT VALLEY FEVER VIRUS; TRANSMISSION; VIROLOGY; VIRUS LOAD;

AEDES; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, INBRED C57BL; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SALIVA; VIRAL LOAD;

EID: 84879519297     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002237     Document Type: Article

References (45)

1. Meegan J, Bailey CL, (1988) Arboviruses Epidemiology and Ecology. CRC Press IV: 51-71.
2. Peters C, Linthicum KL, (1994) Handbook Series in Zoonoses. CRC press section B pp. 125-138.
3. Daubney RHJ, (1931) Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep cattle and man from east Africa. Journal Pathology bacteriol 34: 545-579.
4. Ahmad K, (2000) More deaths from Rift Valley fever in Saudi Arabia and Yemen. Lancet 356: 1422.
5. Bird BH, Ksiazek TG, Nichol ST, Maclachlan NJ, (2009) Rift Valley fever virus. J Am Vet Med Assoc 234: 883-893.
6. Peters CJMJ, (1981) Rift Valley fever. Viral zoonoses 1: 403-420.
7. Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, et al. (2003) Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 37: 1084-1092.
8. McIntosh BM, Russell D, dos Santos I, Gear JH, (1980) Rift Valley fever in humans in South Africa. S Afr Med J 58: 803-806.
9. Meegan JM, Watten RH, Laughlin LW, (1981) Clinical experience with Rift Valley fever in humans during the 1977 Egyptian epizootic. Contrib Epidemiol Biostat 3: 114-123.
10. Schmaljohn C, (2001) Bunyaviridae: the viruses and their replication. Fields Virology 4: 1581-1602.
11. Turell MJ, Linthicum KJ, Patrican LA, Davies FG, Kairo A, et al. (2008) Vector competence of selected African mosquito (Diptera: Culicidae) species for Rift Valley fever virus. J Med Entomol 45: 102-108.
12. Romoser WS, Faran ME, Bailey CL, Lerdthusnee K, (1992) An immunocytochemical study of the distribution of Rift Valley fever virus in the mosquito Culex pipiens. Am J Trop Med Hyg 46: 489-501.
13. Gillespie RD, Mbow ML, Titus RG, (2000) The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol 22: 319-331.
14. Edwards JF, Higgs S, Beaty BJ, (1998) Mosquito feeding-induced enhancement of Cache Valley Virus (Bunyaviridae) infection in mice. J Med Entomol 35: 261-265.
15. Schneider BS, Higgs S, (2008) The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Trans R Soc Trop Med Hyg 102: 400-408.
16. Schneider BS, Soong L, Coffey LL, Stevenson HL, McGee CE, et al. (2010) Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection. PLoS One 5: e11704.
17. Surasombatpattana P, Patramool S, Luplertlop N, Yssel H, Misse D, (2012) Aedes aegypti Saliva Enhances Dengue Virus Infection of Human Keratinocytes by Suppressing Innate Immune Responses. J Invest Dermatol 132: 2103-2105.
18. Reagan KL, Machain-Williams C, Wang T, Blair CD, (2012) Immunization of mice with recombinant mosquito salivary protein D7 enhances mortality from subsequent West Nile virus infection via mosquito bite. PLoS Negl Trop Dis 6: e1935.
19. Osorio JE, Godsey MS, Defoliart GR, Yuill TM, (1996) La Crosse viremias in white-tailed deer and chipmunks exposed by injection or mosquito bite. Am J Trop Med Hyg 54: 338-342.
20. do Valle TZ, Billecocq A, Guillemot L, Alberts R, Gommet C, et al. (2010) A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever. J Immunol 185: 6146-6156.
21. Gommet C, Billecocq A, Jouvion G, Hasan M, Zaverucha do Valle T, et al. (2011) Tissue Tropism and Target Cells of NSs-Deleted Rift Valley Fever Virus in Live Immunodeficient Mice. PLoS Negl Trop Dis 5: e1421.
22. Brown JL, Dominik JW, Morrissey RL, (1981) Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus. Infect Immun 33: 848-853.
23. Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH, (1979) Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg 73: 630-633.
24. Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, et al. (2010) The pathogenesis of Rift Valley fever virus in the mouse model. Virology 407: 256-267.
25. Boonpucknavig S, Vuttiviroj O, Bunnag C, Bhamarapravati N, Nimmanitya S, (1979) Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am J Trop Med Hyg 28: 881-884.
26. Mitrakul C, (1979) Bleeding diathesis in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 10: 434-437.
27. Saito M, Oishi K, Inoue S, Dimaano EM, Alera MT, et al. (2004) Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol 138: 299-303.
28. de Castro RA, de Castro JA, Barez MY, Frias MV, Dixit J, et al. (2007) Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (Rh(0)-D) immune globulin. Am J Trop Med Hyg 76: 737-742.
29. Gray KK, Worthy MN, Juelich TL, Agar SL, Poussard A, et al. (2012) Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl Trop Dis 6: e1529.
30. Limesand KH, Higgs S, Pearson LD, Beaty BJ, (2000) Potentiation of vesicular stomatitis New Jersey virus infection in mice by mosquito saliva. Parasite Immunol 22: 461-467.
31. Schneider BS, Soong L, Girard YA, Campbell G, Mason P, et al. (2006) Potentiation of West Nile encephalitis by mosquito feeding. Viral Immunol 19: 74-82.
32. Chevalier V, Thiongane Y, Lancelot R, (2009) Endemic transmission of Rift Valley Fever in Senegal. Transbound Emerg Dis 56: 372-374.
33. Fontenille D, Traore-Lamizana M, Zeller H, Mondo M, Diallo M, et al. (1995) Short report: Rift Valley fever in western Africa: isolations from Aedes mosquitoes during an interepizootic period. Am J Trop Med Hyg 52: 403-404.
34. Diallo M, Nabeth P, Ba K, Sall AA, Ba Y, et al. (2005) Mosquito vectors of the 1998-1999 outbreak of Rift Valley Fever and other arboviruses (Bagaza, Sanar, Wesselsbron and West Nile) in Mauritania and Senegal. Med Vet Entomol 19: 119-126.
35. Miller BR, Godsey MS, Crabtree MB, Savage HM, Al-Mazrao Y, et al. (2002) Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia. Emerg Infect Dis 8: 1492-1494.
36. Crabtree MB, Kent Crockett RJ, Bird BH, Nichol ST, Erickson BR, et al. (2012) Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Negl Trop Dis 6: e1639.
37. Amraoui F, Krida G, Bouattour A, Rhim A, Daaboub J, et al. (2012) Culex pipiens, an experimental efficient vector of West Nile and Rift Valley fever viruses in the Maghreb region. PLoS One 7: e36757.
38. Muller R, Saluzzo JF, Lopez N, Dreier T, Turell M, et al. (1995) Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg 53: 405-411.
39. Rippy MK, Topper MJ, Mebus CA, Morrill JC, (1992) Rift Valley fever virus-induced encephalomyelitis and hepatitis in calves. Vet Pathol 29: 495-502.
40. Diamond MS, Klein RS, (2004) West Nile virus: crossing the blood-brain barrier. Nat Med 10: 1294-1295.
41. Mook-Kanamori B, Geldhoff M, Troost D, van der Poll T, van de Beek D, (2012) Characterization of a pneumococcal meningitis mouse model. BMC Infect Dis 12: 71.
42. Brett FM, Mizisin AP, Powell HC, Campbell IL, (1995) Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 54: 766-775.
43. Quaresma JA, Duarte MI, Vasconcelos PF, (2006) Midzonal lesions in yellow fever: a specific pattern of liver injury caused by direct virus action and in situ inflammatory response. Med Hypotheses 67: 618-621.
44. Styer LM, Kent KA, Albright RG, Bennett CJ, Kramer LD, et al. (2007) Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog 3: 1262-1270.
45. Hanafi HA, Fryauff DJ, Saad MD, Soliman AK, Mohareb EW, et al. (2011) Virus isolations and high population density implicate Culex antennatus (Becker) (Diptera: Culicidae) as a vector of Rift Valley Fever virus during an outbreak in the Nile Delta of Egypt. Acta Trop 119: 119-124.